CD4 and B-cell chronic lymphocytic leukemia: Although basal STAT5 signalling was significantly increased in both subsets of CD4+ T cells, when patients treated with CIT were compared to patients on BTKi therapy, the basal STAT5 phosphorylation levels were also significantly higher in aTregs compared to Tcons from treated patients with CLL.